World Bulletin/News Desk
The World Health Organization has endorsed using HIV medicines among people who do not have the infection but are at high risk of getting it, and suggested that poor and wealthy countries alike set up pilot projects to better understand the benefits.
The United Nations agency made its suggestion on Friday, four days after U.S. regulators approved use of Gilead Sciences Inc's Truvada for people who are not infected but may engage in sexual activity with HIV-positive partners. The concept is known as pre-exposure prophylaxis (PrEP).
Truvada, which combines the anti-HIV drugs tenofovir and emtricitabine in one pill, is widely used to treat people already infected with the virus that causes AIDS. The medicine, which costs almost $14,000 a year in the United States, is the first treatment also approved for prevention.
"WHO is encouraging countries wishing to introduce PrEP to first establish small projects to help public health workers to better understand and realize its potential benefits," the agency said in a statement. It said appropriate HIV medicines should be given to those at high risk of infection.
"These could include men or transgender women who have sex with men," the group said.
WHO spokeswoman Sarah Russell said the agency could not recommend specific drugs for prevention, but she said, "It needs to be a drug like Truvada that has been developed for prevention purposes."
Russell said WHO expects Gilead to make Truvada available at a deeply discounted price in some poor countries.
"We believe Gilead will bring the price down to about $100 per year per person" in those countries, she said in an interview.
Gilead officials could not immediately be reached for comment.
WHO noted that an international study called Partners PrEP has shown that HIV medicines are highly effective at preventing the illness in men and women whose partners are infected.
That study, conducted in Kenya and Uganda and funded by the Bill & Melinda Gates Foundation, involved taking a daily tablet containing tenofovir or tenofovir in combination with emtricitabine.
The U.N. agency said it would evaluate the outcomes of the small projects, along with evolving scientific evidence, before issuing its own detailed guidelines next year on the use of HIV treatments for prevention.
WHO said it was important that people taking HIV drugs for prevention are HIV-negative because otherwise drug resistant forms of HIV could evolve. The agency said they should also continue using condoms and faithfully take their medicines on a daily basis.
Move meant to create coal jobs and make 'American wealthy again', US president says
African Union's Center for Disease Prevention and Control strategy was launched last week
But the American Copper Buildings going up on the East River -- a complex of two towers with 764 apartments, panoramic views and a huge entrance hall with a doorman -- is different.
The team believes that one day dogs may be replaced by "sniffing" machines, possibly armies of electronic diagnosticians dedicated to analysing samples that people far from clinics would send them by the post.
Three-day African Utility Week conference begins in South African city of Cape Town
"Fortunately dead zones can be reduced by controlling sewage and agricultural runoff into the ocean."
Packs of 10 cigarettes to be scrapped amid coming anti-smoking rules
A glacier is a slow-moving mass of ice formed when snow accumulates year after year, compacting the layers below into a dense body of ice.
A study has shown counseling sessions online had just as much effect as taking regular medication
The finding was recently published in Proceedings of the National Academy of Sciences.
For more than 25 years French car maker Renault has cheated on emissions according to a report which showed that there was a difference of up to 377 percent between the test levels of emissions performance of some of these cars and the on-road levels.
Tuzla, the industrial city housing the power plant, is one of five Balkan cities that are among the 10 most polluted in Europe based on concentrations of particulate matter, according to the World Health Organization.
LEC says the first turbine can generate a maximum capacity of 22 MW, and the second 22 MW turbine is due on line in the next few weeks after testing, with two more to follow by year's end.
The study merely pointed out a correlation, and cannot conclude that having children is the cause of the life expectancy gains, the researchers admitted.
The Arctic's surface temperature has risen by more than two degrees Celsius (3.6 degrees Fahrenheit) since the late 19th century -- double the pace of the world as a whole, with a museum now in France dedicated to show the unique landscape